Literature DB >> 19838657

[Vasculitis and hereditary small vessel diseases].

C Opherk1, N Peters, M Dichgans.   

Abstract

In younger patients with stroke, cerebral vasculitis and hereditary small vessel diseases should be considered as important differential diagnoses. Since the clinical course of cerebral vasculitis is highly variable, diagnostic workup, which includes laboratory tests, CSF analysis, cranial magnetic resonance imaging and biopsy, is often challenging. Therapy should be initiated on an interdisciplinary basis and includes immunosuppressive induction and maintenance regimes. Hereditary small vessel diseases, e.g. CADASIL or Fabry's disease, can mimic clinical features of cerebral vasculitis. Their diagnosis which is based on family history, typical clinical features and genetic analysis often has implications for treatment and genetic counselling.

Entities:  

Mesh:

Year:  2009        PMID: 19838657     DOI: 10.1007/s00108-009-2469-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  [Cerebral vasculitis].

Authors:  P Berlit
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 2.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

3.  Malignant hemispheric infarction in Takayasu arteritis.

Authors:  Thomas Pfefferkorn; H Bitterling; K Hüfner; C Opherk; S Schewe; H W Pfister; A Straube; M Dichgans
Journal:  J Neurol       Date:  2008-06-27       Impact factor: 4.849

4.  Primary angiitis of the central nervous system: emerging variants.

Authors:  K MacLaren; J Gillespie; S Shrestha; D Neary; F W Ballardie
Journal:  QJM       Date:  2005-07-22

5.  Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.

Authors:  Fumiko Tanaka; Atsushi Kawakami; Nozomi Iwanaga; Mami Tamai; Yasumori Izumi; Kouichiro Aratake; Kazuhiko Arima; Makoto Kamachi; Hideki Nakamura; Mingguo Huang; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Journal:  Intern Med       Date:  2006-04-03       Impact factor: 1.271

6.  Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.

Authors:  Karina A Keogh; Steven R Ytterberg; Fernando C Fervenza; Kimberly A Carlson; Darrell R Schroeder; Ulrich Specks
Journal:  Am J Respir Crit Care Med       Date:  2005-10-13       Impact factor: 21.405

Review 7.  Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome.

Authors:  Douglas M Sproule; Petra Kaufmann
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.

Authors:  Martin Dichgans; Hugh S Markus; Stephen Salloway; Auli Verkkoniemi; Margaret Moline; Qin Wang; Holly Posner; Hugues S Chabriat
Journal:  Lancet Neurol       Date:  2008-02-28       Impact factor: 44.182

9.  C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.

Authors:  Anna Richards; Arn M J M van den Maagdenberg; Joanna C Jen; David Kavanagh; Paula Bertram; Dirk Spitzer; M Kathryn Liszewski; Maria-Louise Barilla-Labarca; Gisela M Terwindt; Yumi Kasai; Mike McLellan; Mark Gilbert Grand; Kaate R J Vanmolkot; Boukje de Vries; Jijun Wan; Michael J Kane; Hafsa Mamsa; Ruth Schäfer; Anine H Stam; Joost Haan; Paulus T V M de Jong; Caroline W Storimans; Mary J van Schooneveld; Jendo A Oosterhuis; Andreas Gschwendter; Martin Dichgans; Katya E Kotschet; Suzanne Hodgkinson; Todd A Hardy; Martin B Delatycki; Rula A Hajj-Ali; Parul H Kothari; Stanley F Nelson; Rune R Frants; Robert W Baloh; Michel D Ferrari; John P Atkinson
Journal:  Nat Genet       Date:  2007-07-29       Impact factor: 38.330

10.  A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials.

Authors:  Nils Peters; Jürgen Herzog; Christian Opherk; Martin Dichgans
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

View more
  2 in total

1.  Presymptomatic genetic testing in CADASIL.

Authors:  S Reyes; A Kurtz; D Hervé; E Tournier-Lasserve; H Chabriat
Journal:  J Neurol       Date:  2012-03-15       Impact factor: 4.849

2.  [New aspects of MRI for diagnostics of large vessel vasculitis and primary angiitis of the central nervous system].

Authors:  T Saam; M Habs; C C Cyran; J Grimm; T Pfefferkorn; U Schüller; M F Reiser; K Nikolaou
Journal:  Radiologe       Date:  2010-10       Impact factor: 0.635

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.